← Browse by Condition
Medical Condition
immune related adverse events
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2
NCT07453342
Recruiting
Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge
Enrollment
500 pts
Location
China
Sponsor
Peking Union Medical College H...
NCT06789601 Phase 1, Phase 2
Recruiting
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
Enrollment
100 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT07430579
Recruiting
Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma
Enrollment
25 pts
Location
China
Sponsor
The Second Hospital of Shandon...